Literature DB >> 12650771

Innate and adaptive immune responses to an intracellular bacterium, Francisella tularensis live vaccine strain.

Karen L Elkins1, Siobhán C Cowley, Catharine M Bosio.   

Abstract

The immune response to intracellular bacterium, Francisella tularensis, which causes tularemia and is proposed to be a potential bioterrorism pathogen, has been studied in mice using the attenuated live vaccine strain (LVS). Here we review this infection model, which provides a convenient means of studying protective immune mechanisms not only for Francisella, but also for the large and important class of intracellular pathogens.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12650771     DOI： 10.1016/s1286-4579(02)00084-9

Source DB:  PubMed          Journal:  Microbes Infect        ISSN： 1286-4579            Impact factor:   2.700


  88 in total

1.  Genetic identification of unique immunological responses in mice infected with virulent and attenuated Francisella tularensis.

Authors:  Luke C Kingry; Ryan M Troyer; Nicole L Marlenee; Helle Bielefeldt-Ohmann; Richard A Bowen; Alan R Schenkel; Steven W Dow; Richard A Slayden
Journal:  Microbes Infect       Date:  2010-11-09       Impact factor: 2.700

2.  Characterization of Francisella tularensis outer membrane proteins.

Authors:  Jason F Huntley; Patrick G Conley; Kayla E Hagman; Michael V Norgard
Journal:  J Bacteriol       Date:  2006-11-17       Impact factor: 3.490

3.  Increased Resistance to Intradermal Francisella tularensis LVS Infection by Inactivation of the Sts Phosphatases.

Authors:  Kaustubh Parashar; Erik Kopping; David Frank; Vinaya Sampath; David G Thanassi; Nick Carpino
Journal:  Infect Immun       Date:  2017-08-18       Impact factor: 3.441

4.  CXCR3 and its ligands participate in the host response to Bordetella bronchiseptica infection of the mouse respiratory tract but are not required for clearance of bacteria from the lung.

Authors:  Daniel P Widney; Yan Hu; Amy K Foreman-Wykert; Kim C Bui; Tam T Nguyen; Bao Lu; Craig Gerard; Jeff F Miller; Jeffrey B Smith
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

5.  Toll-like receptor 2 is required for inflammatory responses to Francisella tularensis LVS.

Authors:  Jannet Katz; Ping Zhang; Michael Martin; Stefanie N Vogel; Suzanne M Michalek
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

6.  Identification of Francisella tularensis genes affected by iron limitation.

Authors:  Kaiping Deng; Robert J Blick; Wei Liu; Eric J Hansen
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

7.  Identification of a dominant CD4 T cell epitope in the membrane lipoprotein Tul4 from Francisella tularensis LVS.

Authors:  Michael D Valentino; Lucinda L Hensley; Denise Skrombolas; Pamela L McPherson; Matthew D Woolard; Thomas H Kawula; Jeffrey A Frelinger; John G Frelinger
Journal:  Mol Immunol       Date:  2009-02-23       Impact factor: 4.407

8.  T cells from lungs and livers of Francisella tularensis-immune mice control the growth of intracellular bacteria.

Authors:  Carmen M Collazo; Anda I Meierovics; Roberto De Pascalis; Terry H Wu; C Rick Lyons; Karen L Elkins
Journal:  Infect Immun       Date:  2009-02-23       Impact factor: 3.441

9.  Temporal transcriptional response during infection of type II alveolar epithelial cells with Francisella tularensis live vaccine strain (LVS) supports a general host suppression and bacterial uptake by macropinocytosis.

Authors:  Christopher E Bradburne; Anne B Verhoeven; Ganiraju C Manyam; Saira A Chaudhry; Eddie L Chang; Dzung C Thach; Charles L Bailey; Monique L van Hoek
Journal:  J Biol Chem       Date:  2013-01-15       Impact factor: 5.157

10.  Macrophage proinflammatory response to Francisella tularensis live vaccine strain requires coordination of multiple signaling pathways.

Authors:  Leah E Cole; Araceli Santiago; Eileen Barry; Tae Jin Kang; Kari Ann Shirey; Zachary J Roberts; Karen L Elkins; Alan S Cross; Stefanie N Vogel
Journal:  J Immunol       Date:  2008-05-15       Impact factor: 5.422
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.